Cava Healthcare

Cava Healthcare is a clinical-stage biotechnology company dedicated to the development of novel therapies and diagnostic solutions for complex diseases such as Alzheimer's, cancer, and chronic inflammation. The company's research is primarily based on the work of Dr. Wilfred Jefferies, focusing on the Transporter associated with Antigen Processing (TAP) and its role in immune evasion by tumors. Cava's pipeline includes a diagnostic test for the early detection of Alzheimer's and therapeutic candidates aimed at restoring immune recognition of cancer cells. By integrating advanced diagnostics with targeted treatments, Cava Healthcare aims to provide a comprehensive approach to managing life-threatening conditions.